Cargando…

The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia

PURPOSE: Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by recurrent genetic aberration in leukemic stem cells, namely Philadelphia chromosome caused by reciprocal translocation t(9;22)(q34;q11). In our study, we analyzed the telomeric complex expression and function i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deręgowska, Anna, Pępek, Monika, Solarska, Iwona, Machnicki, Marcin M., Pruszczyk, Katarzyna, Dudziński, Marek, Niesiobędzka-Krężel, Joanna, Seferyńska, Ilona, Sawicki, Waldemar, Wnuk, Maciej, Stokłosa, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374722/ https://www.ncbi.nlm.nih.gov/pubmed/36871092 http://dx.doi.org/10.1007/s00432-023-04662-w

Ejemplares similares

Differential Regulation of Telomeric Complex by BCR-ABL1 Kinase in Human Cellular Models of Chronic Myeloid Leukemia—From Single Cell Analysis to Next-Generation Sequencing
por: Deregowska, Anna, et al.
Publicado: (2020)

Monoubiquitinated Fanconi Anemia D2 (FANCD2-Ub) Is Required for BCR-ABL1 Kinase -Induced Leukemogenesis
por: Koptyra, Mateusz, et al.
Publicado: (2011)

BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
por: Sharma, Nitesh, et al.
Publicado: (2015)

The PERK-eIF2α phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells
por: Kusio-Kobialka, Monika, et al.
Publicado: (2012)

Induction of apoptosis by directing oncogenic Bcr-Abl into the nucleus
por: Huang, Zheng-Lan, et al.
Publicado: (2013)

Telomere Homeostasis: Interplay with Magnesium
por: Maguire, Donogh, et al.
Publicado: (2018)

Analysis of Mutational Profile of Hypopharyngeal and Laryngeal Head and Neck Squamous Cell Carcinomas Identifies KMT2C as a Potential Tumor Suppressor
por: Machnicki, Marcin M., et al.
Publicado: (2022)

On the Interplay of Telomeres, Nevi and the Risk of Melanoma
por: Bodelon, Clara, et al.
Publicado: (2012)

The Functional Interplay Between the t(9;22)-Associated Fusion Proteins BCR/ABL and ABL/BCR in Philadelphia Chromosome-Positive Acute Lymphatic Leukemia
por: Rafiei, Anahita, et al.
Publicado: (2015)

c-Myc activation promotes cofilin-mediated F-actin cytoskeleton remodeling and telomere homeostasis as a response to oxidant-based DNA damage in medulloblastoma cells
por: Lewinska, Anna, et al.
Publicado: (2019)

Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene
Publicado: (1995)

Pharmacological difference between degrader and inhibitor against oncogenic BCR-ABL kinase
por: Shibata, Norihito, et al.
Publicado: (2018)

Synthesis of the l- and d-SH2 domain of the leukaemia oncogene Bcr-Abl
por: Schmidt, Nina, et al.
Publicado: (2022)

Development of protein degradation inducers of oncogenic BCR‐ABL protein by conjugation of ABL kinase inhibitors and IAP ligands
por: Shibata, Norihito, et al.
Publicado: (2017)

Expression of chronic myeloid leukemia oncogenes BCR-ABL (P210) and BCR-ABL (T315I) affect cellular and humoral innate immunity in Drosophila melanogaster
por: Abubaker, Dana, et al.
Publicado: (2022)

Structural and functional dissection of the DH and PH domains of oncogenic Bcr-Abl tyrosine kinase
por: Reckel, Sina, et al.
Publicado: (2017)

Lithium and the Interplay Between Telomeres and Mitochondria in Bipolar Disorder
por: Lundberg, Martin, et al.
Publicado: (2020)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
por: Mian, Afsar Ali, et al.
Publicado: (2012)

Targeting BCR-ABL(+) stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex
por: Chen, Min, et al.
Publicado: (2017)

c-Fos and Dusp1 confer non-oncogene addiction in BCR-ABL induced leukemia
por: Kesarwani, Meenu, et al.
Publicado: (2017)

Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone
por: Malik, Vidhi, et al.
Publicado: (2022)

Co-occurrence of unclassified myeloproliferative neoplasm and giant cell arteritis in a patient treated with allogeneic hematopoietic stem cell transplantation: a case report and literature review
por: Bogucka-Fedorczuk, Aleksandra, et al.
Publicado: (2021)

Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells
por: Kawakami, Shohei, et al.
Publicado: (2022)

Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres
por: Lippert, Timothy P., et al.
Publicado: (2021)

A ‘higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs
por: Schoeftner, Stefan, et al.
Publicado: (2009)

WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene
por: Montano, Giorgia, et al.
Publicado: (2015)

Telomeric recombination induced by dysfunctional telomeres
por: Brault, Marie Eve, et al.
Publicado: (2011)

Telomeric RNAs are essential to maintain telomeres
por: Montero, Juan José, et al.
Publicado: (2016)

Genome assembly in the telomere-to-telomere era
por: Li, Heng, et al.
Publicado: (2023)

The Interplay between Telomeres, Mitochondria, and Chronic Stress Exposure in the Aging Egg
por: Derevyanko, Aksinya, et al.
Publicado: (2022)

BCR: a new target in resistance mediated by BCR/ABL-315I?
por: Haberbosch, Isabella, et al.
Publicado: (2016)

The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteins
por: You, Liangshun, et al.
Publicado: (2016)

Contributions of the RhoGEF activity of p210 BCR/ABL to disease progression
por: Tala, Ilona, et al.
Publicado: (2012)

Expanding the Diversity of Allosteric Bcr-Abl Inhibitors
por: Deng, Xianming, et al.
Publicado: (2010)

An In-House Method for Molecular Monitoring of BCR-ABL
por: Sercan, Hakkı Ogün, et al.
Publicado: (2012)

Depression of oncogenecity by dephosphorylating and degrading BCR-ABL
por: Gao, Miao, et al.
Publicado: (2016)

Alternative lengthening of telomeres: remodeling the telomere architecture
por: Conomos, Dimitri, et al.
Publicado: (2013)

Exercise, Telomeres, and Cancer: “The Exercise-Telomere Hypothesis”
por: Nomikos, Nikitas N., et al.
Publicado: (2018)

Telomere-driven diseases and telomere-targeting therapies
por: Martínez, Paula, et al.
Publicado: (2017)

Telomeres and Telomere Length: A General Overview
por: Srinivas, Nalini, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hqf03fnfoehqefs63pqaku579m